ESMO öncülüğnde yürütülen "Anti-cancer Medicines Availability study" için belli ülkelerdeki bilgilere. ulaşılamadığı için çalışmanın süresi uzatılmıştır.
Çalışmanın kapanmasına çok az bir süre kalması nedeniyle, ivedilikle istenilen bilgiler online olarak aşağıdaki linkten girilip doldurulabilir.
Prof.Dr.Mustafa OZGÜROĞLU
İstanbul Üniversitesi
Cerahpaşa Tıp Fakültesi
Tıbbi Onkoloji Bilim Dalı
Dear colleague,
As an ESMO Faculty member, we are writing with a critical request concerning the
ESMO-led Anti-Cancer Medicines Availability Study. The peer review deadline of this study has just been extended as we are missing reviews for some important countries. We are therefore soliciting your help to review the data and promote the study among your peers.
1. Review the data online - select the tumour types you wish to review
2. Then please leave any comments online here underneath each tumour data table (see below) or send a mail to Nathan Cherny (chernyn@netvision.net.il)
3. Please forward this study to colleagues for their review
This far-reaching study will have an important impact on the current medical landscape and aims to have long-term, hard-hitting consequences on medicine accessibility for patients across Europe.
Kind regards,
The ESMO Emerging Countries Committee
Please paste this url into your browser should you encounter problems:
https://eu.qualtrics.com/SE/?SID=SV_8xdgeNHUhBJ4yuF
Please visit this page for helpful tips on reviewing data:
http://www.esmo.org/Policy/Anti-Cancer-Medicines-Study/Anti-Cancer-Medicines-Study-review
Comments can be left underneath each tumour data table (see below):
